@dansfera: The ripple effect of increased clinical holds is causing serious headaches for development programs across the board. Are companies playing it *too* safe with their strategies? Hear the unfiltered take on whether this current conservative stance is actually accelerating progress or grinding the pharma industry to a halt. Spoiler: The conclusion on this trend isn't pretty for the sector's future. #ClinicalTrials #Pharma #Biotech #FDA #IndustryInsights